WHO Approves Pfizer BioNtech For Caribbean Region

2021-01-07 84

The Pfizer BioNTech vaccine for COVID-19 is now in the COVAX Facility and has been approved for emergency use by the World Health Organisation. What this means is, it's also approved for use in T&T.

The Ministry of Health can't say definitively at this time whether this country would be receiving that particular vaccine, but the healthcare system is equipped to store the initial amount of 50,000 doses in the first instance. Alicia Boucher has more in this report.

Free Traffic Exchange